On March 5, 2024, the official response was that cancer screening is not covered by medical insurance. Regarding the issue that the per capita financing of medical insurance for urban and rural residents in 2022 is only 960 yuan, as well as the expectation that non-first-class items such as tumor screening will be included in the scope of medical insurance payment, we understand this, and hereby give you a detailed answer to the question of per capita financing of medical insurance. According to the current level of medical insurance financing and anti-risk ability, we are temporarily unable to include non-** items such as tumor screening into the scope of medical insurance payment.
It is reported that we are well aware of the importance of preventive medical care to improve people's health, reduce medical costs, and optimize the allocation of medical resources, and we have been working hard to explore how to better include preventive medical care projects in the scope of medical insurance payment.
We are actively studying and promoting the formulation and implementation of relevant policies, in order to ensure the stable operation of medical insurance at the same time, as far as possible to expand the scope of medical insurance payment to meet the growing medical needs of the people, we also encourage all sectors of society, including you, CPPCC members to continue to put forward valuable opinions and suggestions, and jointly promote the development of China's medical security.
We are confident that with the joint efforts of the whole society, we will be able to build a more perfect, fairer and more sustainable medical security system and provide better and more convenient medical services for the people.